OTOM's Global Strategy: "From Talk to Results"; 60 Units Supplied for Indian Government Procurement, Eyes Follow-On TB AI Market

Portable X-ray supplied for AI-integrated public procurement project... Securing a government procurement reference

Portable X-ray (provided by Otom)

OTOM, a company specializing in portable X-ray systems and medical imaging artificial intelligence (AI), is giving its global business strategy greater definition. The company is working to establish a local manufacturing system in the Philippines and develop its business in the Middle East from Abu Dhabi, while in India its efforts have extended to supplying equipment for an actual public procurement project.

According to OTOM, its local partner in India received 60 portable X-ray units for an AI-based portable X-ray procurement project in Andhra Pradesh and began installing them at project sites in early October. The supply is significant because it gives OTOM a record of actual deliveries to India's government procurement market, going beyond a simple overseas sale.

The Andhra Pradesh Medical Services and Infrastructure Development Corporation (APMSIDC) officially held a tender this year for a two-year supply contract covering 100 units of "portable X-ray systems with AI-based reading capabilities." The tender requirements included not only equipment supply but also after-sales service, such as warranties and maintenance.

The Indian project is particularly noteworthy as a case in which participation in public procurement through a local partner led to actual equipment deliveries. It also demonstrates an overseas business model that OTOM could apply in other countries. OTOM's Indian partner, Labindia Healthcare, currently sells OTOM's MINE 2 and MINE ALNU as part of its official product lineup. The National Tuberculosis Elimination Programme (NTEP) of India also names OTOM's Mine 2.1 and Labindia Healthcare as examples of manufacturers and suppliers in its guidelines for operating portable X-ray systems.

The potential for market expansion is another point to watch. In a 2026 tender for portable X-ray systems for tuberculosis screening in Odisha, India, Labindia reportedly submitted the "HDT/OTOM Mine2.1 ALNU" as its proposed product. Although the final award decision for that specific tender is a separate matter, the continued proposal of OTOM products in public health procurement markets across multiple regions of India is an important indicator for assessing the potential for follow-on contracts.

The Indian supply is drawing even more attention because it is bringing together the pieces of OTOM's overseas business that the company has been building. Earlier, OTOM signed a strategic MOU with IONICS EMS, a major Philippine EMS company, to pursue local SKD production of portable X-ray systems, commercialization in the Philippines, and joint research and development and localization of medical imaging AI. IONICS EMS is a key manufacturing affiliate of IONICS Group, which is listed on the Philippine Stock Exchange, and has global manufacturing infrastructure, including an ISO 13485 quality management system for medical devices.

In the Middle East, OTOM is working to expand its business base, with a focus on Abu Dhabi. A Korea-Abu Dhabi industrial cooperation project involving the Abu Dhabi Investment Office (ADIO) and Abdullah Group, among others, has recently gained momentum, supporting the establishment of a local manufacturing and commercialization base for Korean technology companies.

Taken together, OTOM's overseas business strategy is becoming increasingly clear. In the Philippines, the company is securing production capacity and localizing AI; in Abu Dhabi, it is developing business in the Middle East; and in India, it is building a record of government procurement and actual supply. Above all, the supply of 60 units to India is significant because, unlike an MOU or a business plan, it means actual products have been delivered to public healthcare sites overseas. If installation and operation proceed smoothly, the delivery and operational track record that OTOM and its local partner can present in future tenders could be further strengthened.

The next stage OTOM is pursuing is the combination of tuberculosis (TB) screening and medical imaging AI. Portable X-ray systems capture chest images on site, and AI analyzes signs suggestive of TB and the severity of the condition to support healthcare professionals in making follow-up decisions. This approach is particularly relevant to large public health markets such as India, as it can be used in areas with limited access to medical facilities.

OTOM believes that equipping portable X-ray systems with AI-assisted diagnostic solutions could enable immediate severity assessments and emergency patient triage even in remote areas with shortages of radiologists.

OTOM's MINE ALNU is a product authorized for marketing in the United States by the FDA under the 510(k) pathway as a mobile X-ray system. Market observers say it is now necessary to assess OTOM's overseas business not in terms of its "potential to enter" markets, but by whether it can build a repeatable supply model.

If the supply of these 60 units leads to stable on-site operations and provides a basis for expansion into additional state government tenders and tuberculosis screening projects in India, OTOM could establish a business model built around hardware sales, AI integration, and repeat contracts through public procurement.

An OTOM representative said, "The supply for India's public procurement project is a meaningful reference, as it means OTOM's portable X-ray systems have been deployed in an AI-based public health project. Alongside manufacturing localization in the Philippines and market development in the Middle East, we will build up our actual supply and operational experience in India and connect it to follow-on projects, including medical imaging AI."

This content was produced with the assistance of AI translation services.